Antithrombotic Therapy for Chronic Kidney Disease Patients With Concomitant Atrial Fibrillation and Coronary Artery Disease
Background: Oral anticoagulants (OAC) plus antiplatelets is recommended for patients with atrial fibrillation (AF) and coronary artery disease (CAD) to reduce thromboembolism. However, there is limited evidence regarding antithrombotic therapy for patients with concomitant chronic kidney disease (CK...
Main Authors: | Kuo-Hua Lee, Shuo-Ming Ou, Yuan-Chia Chu, Yao-Ping Lin, Ming-Tsun Tsai, Der-Cherng Tarng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-10-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2021.751359/full |
Similar Items
-
Identification of Galectin-3 as Potential Biomarkers for Renal Fibrosis by RNA-Sequencing and Clinicopathologic Findings of Kidney Biopsy
by: Shuo-Ming Ou, et al.
Published: (2021-11-01) -
Artificial Intelligence for Risk Prediction of End-Stage Renal Disease in Sepsis Survivors with Chronic Kidney Disease
by: Kuo-Hua Lee, et al.
Published: (2022-02-01) -
Artificial Intelligence for Risk Prediction of Rehospitalization with Acute Kidney Injury in Sepsis Survivors
by: Shuo-Ming Ou, et al.
Published: (2022-01-01) -
AN69 Filter Membranes with High Ultrafiltration Rates during Continuous Venovenous Hemofiltration Reduce Mortality in Patients with Sepsis-Induced Multiorgan Dysfunction Syndrome
by: Kuo-Hua Lee, et al.
Published: (2021-10-01) -
Comparison of Simplified Creatinine Index and Systemic Inflammatory Markers for Nutritional Evaluation of Hemodialysis Patients
by: Ming-Tsun Tsai, et al.
Published: (2021-05-01)